Evidence map›Paper›PMID 39653802›Full record

ReviewDiabetologia2025

The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD).

Othmar Moser, Dessi P Zaharieva, Peter Adolfsson, Tadej Battelino, Richard M Bracken, Bruce A Buckingham, Thomas Danne, Elizabeth A Davis, Klemen Dovč, Gregory P Forlenza and 16 more

Registry-linked trialAbstract readReviewConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Review in Diabetologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07382856 (Effect of Low-intensity Aerobic Regular Activity on Heart Rate Variability in Type 1 Diabetes), which is not on this map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07382856 naactive not recruitingnot on this map

Effect of Low-intensity Aerobic Regular Activity on Heart Rate Variability in Type 1 Diabetes

TypeinterventionalSponsorUniversity of Banja LukaRan2024 to 2026Enrolled35ConditionsType 1 DiabetesArmslow-intensity physical activity, Intensive insulin therapy
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Observational
  14. Article
  15. Review
  16. Observational
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Othmar Moser *Department of Exercise Physiology and Metabolism (Sportsmedicine), University of Bayreuth, Bayreuth, Germany. othmar.moser@uni-bayreuth.de.ORCID http://orcid.org/0000-0002-1661-0685
Dessi P Zaharieva *Division of Pediatric Endocrinology, Department of Pediatrics, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-9374-8469
Peter AdolfssonDepartment of Pediatrics, Kungsbacka Hospital, Kungsbacka, Sweden.ORCID http://orcid.org/0000-0001-7615-9737
Tadej BattelinoDepartment of Endocrinology, Diabetes and Metabolism, University Medical Center, University Children's Hospital, Ljubljana, Slovenia.ORCID http://orcid.org/0000-0002-0273-4732
Richard M BrackenApplied Sport, Technology, Exercise and Medicine Research Centre, Swansea University, Swansea, UK.ORCID http://orcid.org/0000-0002-6986-6449
Bruce A BuckinghamDivision of Pediatric Endocrinology, Department of Pediatrics, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0003-4581-4887
Thomas DanneBreakthrough T1D (formerly JDRF), New York, NY, USA.ORCID http://orcid.org/0000-0002-8424-3944
Elizabeth A DavisDepartment of Endocrinology and Diabetes, Perth Children's Hospital, Nedlands, WA, Australia.ORCID http://orcid.org/0000-0003-4244-5473
Klemen DovčDepartment of Endocrinology, Diabetes and Metabolism, University Medical Center, University Children's Hospital, Ljubljana, Slovenia.ORCID http://orcid.org/0000-0001-9201-2145
Gregory P ForlenzaBarbara Davis Center for Childhood Diabetes, University of Colorado Denver, Denver, CO, USA.ORCID http://orcid.org/0000-0003-3607-9788
Pieter GillardDepartment of Endocrinology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0001-9111-4561
Sabine E HoferDepartment of Pediatrics, Medical University of Innsbruck, Innsbruck, Austria.ORCID http://orcid.org/0000-0001-6778-0062
Roman HovorkaDepartment of Paediatrics, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0003-2901-461X
Peter G JacobsArtificial Intelligence for Medical Systems, Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0001-9897-4783
Julia K MaderDivision of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0001-7854-4233
Chantal MathieuDepartment of Endocrinology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-4055-5233
Kirsten NørgaardDepartment of Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark.ORCID http://orcid.org/0000-0003-1620-8271
Nick S OliverDivision of Diabetes, Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Imperial College London, London, UK.ORCID http://orcid.org/0000-0003-3525-3633
David N O'NealDepartment of Medicine, University of Melbourne, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0002-0870-4032
John PembertonDepartment of Endocrinology and Diabetes, Birmingham Children's Hospital, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.ORCID http://orcid.org/0000-0002-0730-7879
Rémi Rabasa-LhoretMontreal Clinical Research Institute (IRCM), Montreal, QC, Canada.ORCID http://orcid.org/0000-0003-4706-5170
Jennifer L SherrDivision of Pediatric Endocrinology, Department of Pediatrics, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0001-9301-3043
Harald SourijDivision of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0003-3510-9594
Martin TauschmannDepartment of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-2305-2490
Jane E YardleyMontreal Clinical Research Institute (IRCM), Montreal, QC, Canada.ORCID http://orcid.org/0000-0001-8761-7019
Michael C RiddellSchool of Kinesiology and Health Science, York University, Toronto, ON, Canada.ORCID http://orcid.org/0000-0001-6556-7559

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regular physical activity and exercise (PA) are cornerstones of diabetes care for individuals with type 1 diabetes. In recent years, the availability of automated insulin delivery (AID) systems has improved the ability of people with type 1 diabetes to achieve the recommended glucose target ranges. PA provide additional health benefits but can cause glucose fluctuations, which challenges current AID systems. While an increasing number of clinical trials and reviews are being published on different AID systems and PA, it seems prudent at this time to collate this information and develop a position statement on the topic. This joint European Association for the Study of Diabetes (EASD)/International Society for Pediatric and Adolescent Diabetes (ISPAD) position statement reviews current evidence on AID systems and provides detailed clinical practice points for managing PA in children, adolescents and adults with type 1 diabetes using AID technology. It discusses each commercially available AID system individually and provides guidance on their use in PA. Additionally, it addresses different glucose responses to PA and provides stratified therapy options to maintain glucose levels within the target ranges for these age groups.

Indexed as

Diabetes Mellitus, Type 1ExerciseHypoglycemic AgentsInsulinInsulin Infusion SystemsAdolescentAdultBlood GlucoseChildEuropeHumansBlood GlucoseHypoglycemic AgentsInsulinAutomated insulin deliveryCGMExerciseGlucoseInsulin pumpPhysical activityPosition statementType 1 diabetes

Identifiers

PMID39653802
PMCPMC11732933

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.